Home / CELU : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does CELU make money? Does CELU have pricing power? What's the Earnings Whisper? Will CELU profit more as the business scales? What is CELU's management track record? Is CELU's current price justified?

Celularity Inc.

$1.26 +$0.05 (+4.13%)

NASDAQ · 15 Sep 2026 16:47 UTC

Previous Close

$1.4

Day Range

$1.25$1.33

Year Range

$0.56$2.55

Market Cap

36.47M

AVG Volume

134.75K

Trailing/Forward PE

-0.34/0.84

PEG ratio

Dividend Yield

Next Earnings Date

2026-11-13

Primary Exchange

NASDAQ

Revenue (USD)

CELU Revenue (USD) by quarter
Period	Revenue (USD)
25 Q4	4.1M
25 Q3	5.28M
25 Q2	5.74M
25 Q1	11.43M
24 Q4	18.13M
24 Q3	9.3M
24 Q2	12.11M
24 Q1	14.68M
23 Q4	12.11M
23 Q3	3.79M

Net Income (USD)

CELU Net Income (USD) by quarter
Period	Net Income (USD)
25 Q4	-24.36M
25 Q3	-23.07M
25 Q2	-24.52M
25 Q1	-19.75M
24 Q4	-13.29M
24 Q3	-16.1M
24 Q2	-6.49M
24 Q1	-22.01M
23 Q4	9.55M
23 Q3	-93.88M

Operating Income (USD)

CELU Operating Income (USD) by quarter
Period	Operating Income (USD)
25 Q4	-22.06M
25 Q3	-12.9M
25 Q2	-15.86M
25 Q1	-10.49M
24 Q4	-9.28M
24 Q3	-11.53M
24 Q2	-10.18M
24 Q1	-7.38M
23 Q4	13.31M
23 Q3	-99.26M

EBITDA (USD)

CELU EBITDA (USD) by quarter
Period	EBITDA (USD)
25 Q4	-21.66M
25 Q3	-19.73M
25 Q2	-20.75M
25 Q1	-15.48M
24 Q4	-7.6M
24 Q3	-12.45M
24 Q2	-2.94M
24 Q1	-18.71M
23 Q4	-8.55M
23 Q3	-90.56M

Cash Flows (USD)

CELU Cash Flows (USD) by quarter
Period	Cash Flows (USD)
25 Q4	-5.1M
25 Q3	-4.16M
25 Q2	-999K
25 Q1	-2.99M
24 Q4	1.54M
24 Q3	-179K
24 Q2	-3.48M
24 Q1	-4.44M
23 Q4	-4.92M
23 Q3	-8.55M

EPS (USD)

CELU EPS (USD) by quarter
Period	EPS (USD)
25 Q4	-0.95
25 Q3	-0.88
25 Q2	-1.02
25 Q1	-0.84
24 Q4	-0.59
24 Q3	-0.73
24 Q2	-0.3
24 Q1	-1.03
23 Q4	0.49
23 Q3	-4.99

Expenses (USD)

CELU Expenses (USD) by quarter
Period	Expenses (USD)
25 Q4	18.41M
25 Q3	13.9M
25 Q2	15.99M
25 Q1	17.99M
24 Q4	19.94M
24 Q3	16.6M
24 Q2	19.74M
24 Q1	19.91M
23 Q4	121.72M
23 Q3	16.16M

Cash & Debt (USD)

CELU Cash & Debt (USD) by quarter
Period	Cash & Debt (USD)
25 Q4	6.17M
25 Q3	120K
25 Q2	863K
25 Q1	293K
24 Q4	738K
24 Q3	133K
24 Q2	467K
24 Q1	1.9M
23 Q4	227K
23 Q3	273K

Debt ratios

CELU Debt ratios by quarter
Period	Debt ratios
25 Q4	-0.45
25 Q3	-1.05
25 Q2	-1.23
25 Q1	-1.81
24 Q4	-1.63
24 Q3	-1.62
24 Q2	-0.26
24 Q1	-0.4
23 Q4	-0.32
23 Q3	-0.27

Margins

CELU Margins by quarter
Period	Margins
25 Q4	208.48%
25 Q3	61.81%
25 Q2	8.61%
25 Q1	68.9%
24 Q4	59.5%
24 Q3	58.23%
24 Q2	82.47%
24 Q1	88.83%
23 Q4	20.67%
23 Q3	4.86%

Return on Capital

CELU Return on Capital by quarter
Period	Return on Capital
25 Q4	64.01%
25 Q3	114.83%
25 Q2	96.18%
25 Q1	358.77%
24 Q4	-150.42%
24 Q3	-93.16%
24 Q2	-23.33%
24 Q1	-70.45%
23 Q4	23.31%
23 Q3	-310.36%

Shares Outstanding

CELU Shares Outstanding by quarter
Period	Shares Outstanding
25 Q4	25.6M
25 Q3	26.35M
25 Q2	24.02M
25 Q1	23.53M
24 Q4	22.35M
24 Q3	21.98M
24 Q2	21.85M
24 Q1	21.44M
23 Q4	19.38M
23 Q3	18.83M

Book Value Per Share (USD)

CELU Book Value Per Share (USD) by quarter
Period	Book Value Per Share (USD)
25 Q4	-1.49
25 Q3	-0.76
25 Q2	-1.06
25 Q1	-0.23
24 Q4	0.4
24 Q3	0.79
24 Q2	1.27
24 Q1	1.46
23 Q4	2.11
23 Q3	1.61

Total Assets (USD)

CELU Total Assets (USD) by quarter
Period	Total Assets (USD)
25 Q4	107.33M
25 Q3	114.24M
25 Q2	120.28M
25 Q1	128.88M
24 Q4	132.68M
24 Q3	128.84M
24 Q2	135.49M
24 Q1	143.82M
23 Q4	143.89M
23 Q3	157.19M

Employee Count

CELU Employee Count by quarter
Period	Employee Count
2025	115
2024	123
2023	120
2022	225
2021	225
2019	4

PE Ratio

CELU PE Ratio by quarter
Period	PE Ratio
Aug 23	3.81
Aug 23	4.31
Jul 23	4.68
Jul 23	6.71
Jul 23	5.93
Jul 23	5.96
Jun 23	6.35
Jun 23	7.98
Jun 23	9.65
Jun 23	7.79
Jun 23	8.42
May 23	7.2
May 23	6.82
May 23	5.29
May 23	5.31
Apr 23	6.2
Apr 23	7.22
Apr 23	7.11
Apr 23	7.21
Mar 23	6.51
Nov 22	10.13
Oct 22	10.63
Oct 22	10.31
Oct 22	9.45
Oct 22	9.54
Sep 22	10.49
Sep 22	11.4
Sep 22	9.63
Sep 22	11.17
Sep 22	12.54
Aug 22	13.08
Aug 22	12.81
Aug 22	13.94

Free Cash Flow Yield

CELU Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-36.98%
Sep 26	-36.72%
Sep 26	-30.82%
Aug 26	-32.77%
Aug 26	-64.72%
Aug 26	-74.41%
Aug 26	-73.89%
Jul 26	-81.5%
Jul 26	-69.04%
Jul 26	-66.35%
Jul 26	-69.93%
Jul 26	-83.55%
Jun 26	-83.51%
Jun 26	-68.82%
Jun 26	-72.63%
Jun 26	-59.36%
May 26	-51.26%
May 26	-59.51%
May 26	-64.06%
May 26	-58.84%
May 26	-54.1%
Apr 26	-22.61%
Apr 26	-20.41%
Apr 26	-19.76%
Apr 26	-18.87%
Mar 26	-20.57%
Mar 26	-20.57%
Mar 26	-20.57%
Mar 26	-20.74%
Feb 26	-20.41%
Feb 26	-18.59%
Feb 26	-19.92%
Feb 26	-19.31%
Jan 26	-20.57%
Jan 26	-19.46%
Jan 26	-19.16%
Jan 26	-19.31%
Jan 26	-20.74%
Dec 25	-18.73%
Dec 25	-17.31%
Dec 25	-15.69%
Dec 25	-12.68%
Nov 25	-12.55%
Nov 25	-14.34%
Nov 25	-16.19%
Nov 25	-6.16%
Oct 25	-5.62%
Oct 25	-5.3%
Oct 25	-5.54%
Oct 25	-5.35%
Oct 25	-5.15%
Sep 25	-4.87%
Sep 25	-4.94%
Sep 25	-4.72%
Sep 25	-4.55%
Aug 25	-2.78%
Aug 25	-7.75%
Aug 25	-8.44%
Aug 25	-9.06%
Aug 25	-9.41%
Jul 25	-9.92%
Jul 25	-9.69%
Jul 25	-13.91%
Jul 25	-14.83%
Jun 25	-15.87%
Jun 25	-16.68%
Jun 25	-16.78%
Jun 25	-14.11%
May 25	-13.91%
May 25	-12.82%
May 25	-14.39%
May 25	-17.58%
May 25	-37.03%
Apr 25	-36.8%
Apr 25	-37.98%
Apr 25	-36.13%
Apr 25	-42.93%
Mar 25	-33.47%
Mar 25	-32.55%
Mar 25	-38.23%
Mar 25	-48.17%
Feb 25	-51.08%
Feb 25	-35.27%
Feb 25	-27.69%
Feb 25	-27.43%
Jan 25	-28.9%
Jan 25	-23.7%
Jan 25	-25.76%
Jan 25	-27.43%
Jan 25	-25.76%
Dec 24	-26.45%
Dec 24	-25.43%
Dec 24	-26.69%
Dec 24	-25.11%
Nov 24	-47.99%
Nov 24	-35.47%
Nov 24	-39.8%
Nov 24	-27.58%
Nov 24	-93.83%
Oct 24	-72.65%

Price to Sales

CELU Price to Sales by quarter
Period	Price to Sales
Sep 26	1.35
Sep 26	1.36
Sep 26	1.62
Aug 26	1.52
Aug 26	0.77
Aug 26	0.67
Aug 26	0.68
Jul 26	0.61
Jul 26	0.72
Jul 26	0.75
Jul 26	0.71
Jul 26	0.6
Jun 26	0.6
Jun 26	0.73
Jun 26	0.69
Jun 26	0.84
May 26	0.97
May 26	0.84
May 26	0.78
May 26	0.85
May 26	0.92
Apr 26	0.72
Apr 26	0.8
Apr 26	0.82
Apr 26	0.86
Mar 26	0.79
Mar 26	0.79
Mar 26	0.79
Mar 26	0.79
Feb 26	0.8
Feb 26	0.88
Feb 26	0.82
Feb 26	0.84
Jan 26	0.79
Jan 26	0.84
Jan 26	0.85
Jan 26	0.84
Jan 26	0.79
Dec 25	0.87
Dec 25	0.94
Dec 25	1.04
Dec 25	1.29
Nov 25	1.3
Nov 25	1.14
Nov 25	1.01
Nov 25	0.96
Oct 25	1.05
Oct 25	1.12
Oct 25	1.07
Oct 25	1.1
Oct 25	1.15
Sep 25	1.21
Sep 25	1.2
Sep 25	1.25
Sep 25	1.3
Aug 25	2.12
Aug 25	1.56
Aug 25	1.43
Aug 25	1.34
Aug 25	1.29
Jul 25	1.22
Jul 25	1.25
Jul 25	0.87
Jul 25	0.82
Jun 25	0.76
Jun 25	0.73
Jun 25	0.72
Jun 25	0.86
May 25	0.87
May 25	0.94
May 25	0.84
May 25	0.69
May 25	0.73
Apr 25	0.73
Apr 25	0.71
Apr 25	0.75
Apr 25	0.63
Mar 25	0.81
Mar 25	0.83
Mar 25	0.71
Mar 25	0.56
Feb 25	0.53
Feb 25	0.77
Feb 25	0.98
Feb 25	0.98
Jan 25	0.93
Jan 25	1.14
Jan 25	1.05
Jan 25	0.98
Jan 25	1.05
Dec 24	1.02
Dec 24	1.06
Dec 24	1.01
Dec 24	1.08
Nov 24	1.04
Nov 24	1.41
Nov 24	1.26
Nov 24	1.82
Nov 24	0.92
Oct 24	1.19

EV/EBITDA

CELU EV/EBITDA by quarter
Period	EV/EBITDA
Nov 22	7.19
Oct 22	7.56
Oct 22	7.32
Oct 22	6.69
Oct 22	6.76
Sep 22	7.46
Sep 22	8.12
Sep 22	6.82
Sep 22	7.96
Sep 22	8.96
Aug 22	9.36
Aug 22	9.16
Aug 22	9.99

Price to Book

CELU Price to Book by quarter
Period	Price to Book
Aug 25	9.59
Aug 25	8.8
Aug 25	8.2
Aug 25	7.89
Jul 25	7.49
Jul 25	7.66
Jul 25	5.34
Jul 25	5.01
Jun 25	4.68
Jun 25	4.45
Jun 25	4.43
Jun 25	5.26
May 25	5.34
May 25	5.79
May 25	5.16
May 25	4.22
May 25	2.03
Apr 25	2.05
Apr 25	1.98
Apr 25	2.09
Apr 25	1.76
Mar 25	2.25
Mar 25	2.31
Mar 25	1.97
Mar 25	1.56
Feb 25	1.48
Feb 25	2.14
Feb 25	2.72
Feb 25	2.75
Jan 25	2.61
Jan 25	3.18
Jan 25	2.93
Jan 25	2.75
Jan 25	2.93
Dec 24	2.85
Dec 24	2.96
Dec 24	2.82
Dec 24	3
Nov 24	1.6
Nov 24	2.17
Nov 24	1.93
Nov 24	2.79
Nov 24	0.99
Oct 24	1.28
Oct 24	1.72
Oct 24	1.19
Oct 24	1.25
Sep 24	1.41
Sep 24	1.41
Sep 24	1.32
Sep 24	1.33
Aug 24	1.46
Aug 24	1.49
Aug 24	1.45
Aug 24	1.33
Aug 24	1.43
Jul 24	1.95
Jul 24	1.88
Jul 24	1.84
Jul 24	1.83
Jun 24	1.95
Jun 24	1.9
Jun 24	2
Jun 24	2.02
May 24	1.94
May 24	2.15
May 24	1.87
May 24	1.84
May 24	2.05
Apr 24	1.88
Apr 24	1.89
Apr 24	2.56
Apr 24	3.31
Mar 24	3.26
Mar 24	3.23
Mar 24	3.54
Mar 24	3.85
Mar 24	2.28
Feb 24	2.89
Feb 24	2.7
Feb 24	2.66
Feb 24	3.36
Jan 24	2.14
Jan 24	1.83
Jan 24	1.35
Jan 24	1.53
Dec 23	0.37
Dec 23	0.27
Dec 23	0.28
Dec 23	0.31
Dec 23	0.34
Nov 23	0.32
Nov 23	0.31
Nov 23	0.33
Nov 23	0.35
Oct 23	0.31
Oct 23	0.35
Oct 23	0.44
Oct 23	0.32
Sep 23	0.33

No video analysis for this stock yet. Request one from our team.

News: CELU

gurufocus.com · 27 Aug 2026

Celularity and MuseCell Innovations® Announce U.S. Manufacturing Collaboration for the Dezawa MuseCell® Platform

[url="]Celularity Inc.[/url] (Nasdaq: CELU) (âCelularityâ), a longevity-focused regenerative and cellular medicine company, and [url="]MuseCell InnovationsÂ

businesswire.com · 27 Aug 2026

Celularity and MuseCell Innovations® Announce U.S. Manufacturing Collaboration for the Dezawa MuseCell® Platform

FLORHAM PARK, N.J. & SINGAPORE--(BUSINESS WIRE)--Celularity Inc. and MuseCell Innovations announce U.S. manufacturing partnership for production of Dezawa MuseCells in Florham Park, NJ facility.

globenewswire.com · 25 Aug 2026

Celularity Provides Update Regarding Nasdaq Listing Compliance

FLORHAM PARK, N.J., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (the “Company”) today announced that, on August 21, 2026, it received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC stating that, because the Company has not filed its Quarterly Report on Form 10-Q for the period ended June 30, 2026 and remains delinquent in filing its Quarterly Report on Form 10-Q for the period ended March 31, 2026, the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1). Nasdaq Listing Rule 5250(c)(1) requires listed companies to timely file all required periodic financial reports with the U.S. Securities and Exchange Commission.

AI Analysis

Celularity Inc.

Video analysis: CELU

News: CELU

Celularity and MuseCell Innovations® Announce U.S. Manufacturing Collaboration for the Dezawa MuseCell® Platform

Celularity and MuseCell Innovations® Announce U.S. Manufacturing Collaboration for the Dezawa MuseCell® Platform

Celularity Provides Update Regarding Nasdaq Listing Compliance

Similar companies